IL1B and cryopyrin-associated periodic syndrome: Given that the soluble IL-1 receptors effectively neutralize IL-1β levels, resulting in indistinguishable systemic IL-1β concentrations between CAPS patients—who typically overproduce this cytokine—and healthy individuals, it is even less likely to observe differences in IL-1β levels among healthy individuals across different age groups.